Variant report
Variant | nsv983519 |
---|---|
Chromosome Location | chr13:62384475-62408937 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568440290 | chr13:62384479-62384480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528852320 | chr13:62384517-62384518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368559691 | chr13:62384526-62384527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565349698 | chr13:62384541-62384542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148789567 | chr13:62384582-62384583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs199916353 | chr13:62384596-62384597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185357221 | chr13:62384600-62384601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533384819 | chr13:62384611-62384612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189381048 | chr13:62384628-62384629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569717589 | chr13:62384709-62384710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs143877221 | chr13:62384710-62384711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546712309 | chr13:62384723-62384724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371026289 | chr13:62384736-62384737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574030983 | chr13:62384778-62384779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541342513 | chr13:62384791-62384792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554162418 | chr13:62384811-62384812 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146402872 | chr13:62384813-62384814 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545941770 | chr13:62384843-62384844 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs113218536 | chr13:62384936-62384937 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375039820 | chr13:62384947-62384948 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs75043116 | chr13:62384981-62384982 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535796760 | chr13:62384993-62384994 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192628623 | chr13:62385063-62385064 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs184978361 | chr13:62385070-62385071 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549154262 | chr13:62385077-62385078 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs188097432 | chr13:62385180-62385181 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529507193 | chr13:62385186-62385187 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs139681130 | chr13:62385197-62385198 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565311026 | chr13:62385203-62385204 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs116247703 | chr13:62385211-62385212 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144405291 | chr13:62385226-62385227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs569761186 | chr13:62385240-62385241 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs118057139 | chr13:62385292-62385293 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549158306 | chr13:62385323-62385324 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs567472095 | chr13:62385325-62385326 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534885748 | chr13:62385342-62385343 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs553318417 | chr13:62385398-62385399 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112885117 | chr13:62385443-62385444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs375579200 | chr13:62385445-62385446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs151052760 | chr13:62385446-62385447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs576519627 | chr13:62385515-62385516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543521676 | chr13:62385537-62385538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561901929 | chr13:62385542-62385543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573920702 | chr13:62385550-62385551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs541293292 | chr13:62385583-62385584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559654970 | chr13:62385623-62385624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79827375 | chr13:62385646-62385647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs577695707 | chr13:62385658-62385659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs141000344 | chr13:62385664-62385665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533764342 | chr13:62385667-62385668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:62384200-62384800 | Enhancers | Brain Substantia Nigra | brain |
2 | chr13:62384400-62385800 | Enhancers | Brain Germinal Matrix | brain |
3 | chr13:62384600-62384800 | Enhancers | Brain Hippocampus Middle | brain |
4 | chr13:62384600-62385400 | Enhancers | Brain Angular Gyrus | brain |
5 | chr13:62384800-62385400 | Weak transcription | Brain Hippocampus Middle | brain |
6 | chr13:62385400-62386200 | Enhancers | Brain Hippocampus Middle | brain |
7 | chr13:62387600-62388000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr13:62391000-62391400 | Enhancers | Fetal Muscle Leg | muscle |
9 | chr13:62391400-62392200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr13:62404600-62405600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr13:62404800-62405400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr13:62405000-62405200 | Enhancers | Fetal Brain Male | brain |